BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 30089595)

  • 1. Computed tomography characteristics of lung adenocarcinomas with epidermal growth factor receptor mutation: A propensity score matching study.
    Suh YJ; Lee HJ; Kim YJ; Kim KG; Kim H; Jeon YK; Kim YT
    Lung Cancer; 2018 Sep; 123():52-59. PubMed ID: 30089595
    [TBL] [Abstract][Full Text] [Related]  

  • 2. EGFR L858R mutation is associated with lung adenocarcinoma patients with dominant ground-glass opacity.
    Yang Y; Yang Y; Zhou X; Song X; Liu M; He W; Wang H; Wu C; Fei K; Jiang G
    Lung Cancer; 2015 Mar; 87(3):272-7. PubMed ID: 25582278
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Associations between clinical data and computed tomography features in patients with epidermal growth factor receptor mutations in lung adenocarcinoma.
    Cao Y; Xu H; Liao M; Qu Y; Xu L; Zhu D; Wang B; Tian S
    Int J Clin Oncol; 2018 Apr; 23(2):249-257. PubMed ID: 28988295
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Epidermal growth factor receptor mutation in lung adenocarcinomas: relationship with CT characteristics and histologic subtypes.
    Lee HJ; Kim YT; Kang CH; Zhao B; Tan Y; Schwartz LH; Persigehl T; Jeon YK; Chung DH
    Radiology; 2013 Jul; 268(1):254-64. PubMed ID: 23468578
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Radiogenomic correlation in lung adenocarcinoma with epidermal growth factor receptor mutations: Imaging features and histological subtypes.
    Hong SJ; Kim TJ; Choi YW; Park JS; Chung JH; Lee KW
    Eur Radiol; 2016 Oct; 26(10):3660-8. PubMed ID: 26787602
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CT Features Associated with Epidermal Growth Factor Receptor Mutation Status in Patients with Lung Adenocarcinoma.
    Liu Y; Kim J; Qu F; Liu S; Wang H; Balagurunathan Y; Ye Z; Gillies RJ
    Radiology; 2016 Jul; 280(1):271-80. PubMed ID: 26937803
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Computed tomography and clinical features associated with epidermal growth factor receptor mutation status in stage I/II lung adenocarcinoma.
    Zou J; Lv T; Zhu S; Lu Z; Shen Q; Xia L; Wu J; Song Y; Liu H
    Thorac Cancer; 2017 May; 8(3):260-270. PubMed ID: 28383802
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Discrepancy of epidermal growth factor receptor mutation in lung adenocarcinoma presenting as multiple ground-glass opacities.
    Liu M; He WX; Song N; Yang Y; Zhang P; Jiang GN
    Eur J Cardiothorac Surg; 2016 Nov; 50(5):909-913. PubMed ID: 27032467
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Relationships between EGFR mutation status of lung cancer and preoperative factors - are they predictive?
    Usuda K; Sagawa M; Motono N; Ueno M; Tanaka M; Machida Y; Matoba M; Taniguchi M; Tonami H; Ueda Y; Sakuma T
    Asian Pac J Cancer Prev; 2014; 15(2):657-62. PubMed ID: 24568474
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Adenocarcinomas with predominant ground-glass opacity: correlation of morphology and molecular biomarkers.
    Aoki T; Hanamiya M; Uramoto H; Hisaoka M; Yamashita Y; Korogi Y
    Radiology; 2012 Aug; 264(2):590-6. PubMed ID: 22653188
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Correlation between epidermal growth factor receptor mutation and histologic subtypes or characteristics of computed tomography findings in patients with resected pulmonary adenocarcinoma.
    Wang D; Yan N; Yang X; Ge Y; Xu D; Shao G; Peng Z
    J Cancer Res Ther; 2018 Jan; 14(1):240-244. PubMed ID: 29516992
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical and CT characteristics of surgically resected lung adenocarcinomas harboring ALK rearrangements or EGFR mutations.
    Wang H; Schabath MB; Liu Y; Han Y; Li Q; Gillies RJ; Ye Z
    Eur J Radiol; 2016 Nov; 85(11):1934-1940. PubMed ID: 27776643
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ground glass opacities: Imaging, pathology, and gene mutations.
    Sun F; Xi J; Zhan C; Yang X; Wang L; Shi Y; Jiang W; Wang Q
    J Thorac Cardiovasc Surg; 2018 Aug; 156(2):808-813. PubMed ID: 29753514
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Epidermal growth factor receptor mutation status in stage I lung adenocarcinoma with different image patterns.
    Hsu KH; Chen KC; Yang TY; Yeh YC; Chou TY; Chen HY; Tsai CR; Chen CY; Hsu CP; Hsia JY; Chuang CY; Tsai YH; Chen KY; Huang MS; Su WC; Chen YM; Hsiung CA; Chang GC; Chen CJ; Yang PC
    J Thorac Oncol; 2011 Jun; 6(6):1066-72. PubMed ID: 21512404
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Correlation between EGFR mutation status and computed tomography features in patients with advanced pulmonary adenocarcinoma.
    Hsu JS; Huang MS; Chen CY; Liu GC; Liu TC; Chong IW; Chou SH; Yang CJ
    J Thorac Imaging; 2014 Nov; 29(6):357-63. PubMed ID: 25303964
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Are there imaging characteristics associated with epidermal growth factor receptor and KRAS mutations in patients with adenocarcinoma of the lung with bronchioloalveolar features?
    Glynn C; Zakowski MF; Ginsberg MS
    J Thorac Oncol; 2010 Mar; 5(3):344-8. PubMed ID: 20087229
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Epidermal growth factor receptor mutation and pathologic-radiologic correlation between multiple lung nodules with ground-glass opacity differentiates multicentric origin from intrapulmonary spread.
    Chung JH; Choe G; Jheon S; Sung SW; Kim TJ; Lee KW; Lee JH; Lee CT
    J Thorac Oncol; 2009 Dec; 4(12):1490-5. PubMed ID: 19844187
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Relationship between EGFR Mutations and Pathological Classification and 
Specimen of Lung Adenocarcinoma].
    Kang L; Zheng J; Zhu X
    Zhongguo Fei Ai Za Zhi; 2017 Jun; 20(6):382-388. PubMed ID: 28641695
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association between high-resolution computed tomography findings and the IASLC/ATS/ERS classification of small lung adenocarcinomas in Japanese patients.
    Kudo Y; Matsubayashi J; Saji H; Akata S; Shimada Y; Kato Y; Kakihana M; Kajiwara N; Ohira T; Nagao T; Ikeda N
    Lung Cancer; 2015 Oct; 90(1):47-54. PubMed ID: 26259875
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Relation of EGFR Mutation Status to Metabolic Activity in Localized Lung Adenocarcinoma and Its Influence on the Use of FDG PET/CT Parameters in Prognosis.
    Kim YI; Paeng JC; Park YS; Cheon GJ; Lee DS; Chung JK; Kang KW
    AJR Am J Roentgenol; 2018 Jun; 210(6):1346-1351. PubMed ID: 29547059
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.